CLPP and squamous cell lung carcinoma: Zhou et al. developed the activator of hClpP ZK53 [7] that in lung squamous cell carcinoma (LUSC) models, promoted ClpP-mediated degradation of ETC proteins, thereby disrupting OXPHOS, inducing energetic stress, and blocking G1 cell cycle phase.